Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Aap Implantate AG

Start price
Target price
Perf. (%)
€1.47
22.01.26
-
22.01.29
6.12%
08:37

buy
Aap Implantate AG

Start price
Target price
Perf. (%)
€1.48
07.06.25
-
07.06.28
22.97%
14.07.25

buy
Aap Implantate AG

Start price
Target price
Perf. (%)
€0.79
15.04.24
€2.00
15.04.25
80.89%
16.04.25

Top 10 in its market
Revenue growth >5% per year expected
Future proof or reliable business model
Higher EBIT margin than peer group
Aap Implantate AG

Start price
Target price
Perf. (%)
€0.98
04.07.23
€0.000
04.07.24
-19.90%
15.04.24

Top 10 in its market
Revenue growth >5% per year expected
Future proof or reliable business model
Higher EBIT margin than peer group
buy
Aap Implantate AG

Start price
Target price
Perf. (%)
€1.12
12.06.23
€2.00
12.06.24
-12.50%
24.06.23

Top 10 in its market
Revenue growth >5% per year expected
Future proof or reliable business model
Higher EBIT margin than peer group
buy
Aap Implantate AG

Start price
Target price
Perf. (%)
€1.05
29.05.23
€12.00
29.05.24
-16.67%
21.06.23

Aap Implantate AG

Start price
Target price
Perf. (%)
€1.07
27.05.23
€1.00
27.05.24
4.67%
10.06.23

buy
Aap Implantate AG

Start price
Target price
Perf. (%)
€1.31
03.01.23
-
03.01.24
10.69%
26.04.23

Aap Implantate AG

Start price
Target price
Perf. (%)
€3.04
20.04.22
-
20.04.23
-48.36%
21.04.23

Probably not worthwhile Investment
Revenue decline/stagnation expected
High valuation
Below average Management
buy
Aap Implantate AG

Start price
Target price
Perf. (%)
€3.20
16.04.22
-
16.04.23
-5.63%
30.04.22

Top 10 in its market
Revenue growth >5% per year expected
Future proof or reliable business model
Higher EBIT margin than peer group
buy
Aap Implantate AG

Start price
Target price
Perf. (%)
€3.31
21.02.21
€4.00
21.02.22
-4.39%
22.02.22

Top 10 in its market
Revenue growth >5% per year expected
Future proof or reliable business model
Higher EBIT margin than peer group